Isaacson, Stuart H.
Dashtipour, Khashayar
Mehdirad, Ali A.
Peltier, Amanda C.
Article History
Accepted: 21 January 2021
First Online: 9 March 2021
Compliance with Ethical Standards
:
: SH Isaacson has served as a consultant and received honoraria for CME, research grants, and/or promotional speaker on behalf of AbbVie, Acadia, Acorda, Adamas, Addex, Affiris, Alexva, Allergan, Amarantus, Amneal, Axovant, Benevolent, Biogen, Britannia, Cadent, Cala, Cerecor, Cipla, Eli Lilly, Enterin, GE Healthcare, Global Kinetics, Impax, Impel, Intec Pharma, Ipsen, Jazz, Kyowa, Lundbeck, Merz, Michael J. Fox Foundation, Mitsubishi Tanabe, Neuralym, Neurocrine, Neuroderm, Parkinson Study Group, Pharma2B, Prilenia, Promentis, Revance, Roche, Sanofi, Sunovion, Sun Pharma, Teva, Theravance, UCB, US World Meds, and Zambon. K Dashtipour has served as an advisor, consultant, or speaker for AbbVie, Acadia, Acorda, Adamas, Allergan, Amneal, Ipsen, Kyowa Kirin, Lundbeck, Neurocrine, Revance, Sunovion, Teva, and US WorldMeds. AA Mehdirad has served as a speaker for Lundbeck, Pfizer, and Bristol-Myers Squibb. AC Peltier has received fees for consultancy, honoraria, and/or travel/lodging from Lundbeck, Alnylam and Akcea, CSL Behring, and Daiichi Sankyo Inc.
: This article does not contain any studies with human or animal subjects performed by any of the authors.